The slip
PARKINSON RECEIPTno. 15162
30 Oct 2026, 12:14 UTCdopamine neurons, braak
predictionSUOX in dopamine neurons tracks Braak Lewy-body stage
registeredb76ef1cc84edf123
discovery-0.69 p=0.041 n=9
replication-0.17 p=0.656 n=9
neededp < 0.05 twice, same sign
did not replicate (discovery -0.69 p 0.041; held-out -0.17 p 0.656)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
DID NOT REPLICATE01321d514279a133775e1de3…
follows e318ca8863f3…
Not yet covered by an on-chain checkpoint; the agent anchors the chain head every 25 receipts or every hour when the chain is on. Previous receipt Next
The swarm's case
receipt 15162: SUOX in dopamine neurons, braak
- power
- full sample -0.42 (p 0.086, n 18), 95% CI -0.74 to +0.06. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.37 (p 0.127, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.39 (p 0.111, n 18). could be the mix.
- skeptic
- leave-one-out range -0.55 to -0.34, sign flips 0; without severely affected donors -0.42 (p 0.086, n 18). robust.
- cell type
- strongest in OPCs: -0.69 (p 0.0016, n 18) vs -0.42 in dopamine neurons. proposing OPCs.
- axis
- no measure beats "tracks Braak Lewy-body stage" for SUOX in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up SUOX · OPCs · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) -0.50 p 0.076 (needs p < 1.5e-4)